Back to 
Assenagon Asset Management S.A.
Assenagon Asset Management S.A.
CLDXShowing 4 of 6 quarters
Position history for Assenagon Asset Management S.A.'s holdings in Celldex Therapeutics, Inc.
Assenagon Asset Management S.A. holds 788,696 shares of CLDX (Celldex Therapeutics, Inc.), worth $29.3M as of 2026-Q2. The position was increased (+438.3% shares). CLDX represents 0.0% of Assenagon Asset Management S.A.'s portfolio.
Current Value
$29.3M
Current Shares
788,696
Total Value Change
+$28.6M
Total Shares Change
+767,750
Quarter-by-Quarter History
Other major holders of CLDX: BNP PARIBAS FINANCIAL MARKETS, WELLINGTON MANAGEMENT GROUP LLP